News

Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study ...
PharmiWeb4d
PharmaNest Launches FibroMAP, the First Single-Fiber Phenotypic Tool for the Study of Fibrosis Across Biological Models and Indications
FibroMAP combines the power of high-resolution, single-fiber, and spatially resolved datasets generated by PharmaNest's digital pathology and image analysis platform (FibroNest) with advanced ...
Cancer Therapy Advisor3d
Using Liquid and Tissue Biopsy Results to Guide Treatment May Provide Benefits
Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.
eLife4d
Human RAP2A Homolog of the Drosophila Asymmetric Cell Division Regulator Rap2l Targets the Stemness of Glioblastoma Stem Cells
This useful study explores the role of RAP2A in asymmetric cell division (ACD) regulation in glioblastoma stem cells (GSCs), drawing parallels to Drosophila ACD mechanisms and proposing that an ...
Cure Today6d
An AI-Driven Companion Diagnostic Receives FDA Designation in NSCLC
More Information on the AI-Driven Companion Diagnostic, the Ventana TROP2 RxDx Device The Ventana TROP2 RxDx Device is a computational pathology device — a diagnostic system — that can analyze digital ...
Fluorescence Microscopy Market to Reach $1.3 Billion by 2029
This report covers product types such as upright and inverted microscopes and segments the market by illumination method, component, technology, and end-use. It assesses current market status, ...
University of Mississippi2d
Transfer Equivalencies
Transfer equivalencies determine how courses from other institutions align with our university’s curriculum, ensuring students receive appropriate credit for their previous coursework. Use this page ...